Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
depression
MedTech
FDA approves 1st nondrug, at-home treatment for depression
The FDA issued a green light that covers the wearable's use both as a standalone treatment and in combination with other medications.
Conor Hale
Dec 11, 2025 6:00am
Reunion's psychedelic reduces postpartum depression in ph. 2
Aug 18, 2025 7:52am
Beckley Psytech psychedelic reduces depression symptoms in ph. 2
Jul 1, 2025 8:30am
Gilgamesh links psychedelic to 94% remission rate in depression
May 27, 2025 11:00am
Neumora rethinks depression drug strategy after ph. 3 failure
Mar 3, 2025 11:00am
Supernus depression drug candidate fails midstage trial
Feb 19, 2025 6:40am
